Book contents
- Frontmatter
- Contents
- Introduction
- Participants
- Non-Participant Contributors
- Part 1 Transmissible diseases with long development times and vaccination strategies
- Overview of data analysis: diseases with long development times
- HPV and cervical cancer
- An age-structured model for measles vaccination
- Invited Discussion
- Invited Discussion
- Piece-wise constant models to estimate age- and time-specific incidence of toxoplasmosis from age- and time-specific seroprevalence data
- New methodology for AIDS back calculation
- Imperfect HIV vaccines, the consequences for epidemic control and clinical trials
- Feasibility of prophylactic HIV-vaccine trials: some statistical issues
- The design of immunisation programmes against hepatitis B virus in developing countries
- The effect of different mixing patterns on vaccination programs
- Optimal vaccination patterns in age-structured populations I: the reproduction number
- Optimal vaccination patterns in age-structured populations II: optimal strategies
- Part 2 Dynamics of immunity (development of disease within individuals)
- Part 3 Population heterogeneity (mixing)
- Part 4 Consequences of treatment interventions
- Part 5 Prediction
Piece-wise constant models to estimate age- and time-specific incidence of toxoplasmosis from age- and time-specific seroprevalence data
Published online by Cambridge University Press: 04 August 2010
Book contents
- Frontmatter
- Contents
- Introduction
- Participants
- Non-Participant Contributors
- Part 1 Transmissible diseases with long development times and vaccination strategies
- Overview of data analysis: diseases with long development times
- HPV and cervical cancer
- An age-structured model for measles vaccination
- Invited Discussion
- Invited Discussion
- Piece-wise constant models to estimate age- and time-specific incidence of toxoplasmosis from age- and time-specific seroprevalence data
- New methodology for AIDS back calculation
- Imperfect HIV vaccines, the consequences for epidemic control and clinical trials
- Feasibility of prophylactic HIV-vaccine trials: some statistical issues
- The design of immunisation programmes against hepatitis B virus in developing countries
- The effect of different mixing patterns on vaccination programs
- Optimal vaccination patterns in age-structured populations I: the reproduction number
- Optimal vaccination patterns in age-structured populations II: optimal strategies
- Part 2 Dynamics of immunity (development of disease within individuals)
- Part 3 Population heterogeneity (mixing)
- Part 4 Consequences of treatment interventions
- Part 5 Prediction
- Type
- Chapter
- Information
- Models for Infectious Human DiseasesTheir Structure and Relation to Data, pp. 67 - 71Publisher: Cambridge University PressPrint publication year: 1996